Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine and DLI for Relapsed AML Post-Transplant
NCT01758367Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2012
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in acute myeloid leukemia (AML), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
decitabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01758367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01758367.